Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy

被引:0
|
作者
Antoine, C [1 ]
Garnier, JL [1 ]
Duboust, A [1 ]
Bariety, J [1 ]
Stevenson, G [1 ]
Glotz, D [1 ]
机构
[1] HOP EDOUARD HERRIOT,RENAL TRANSPLANTAT UNIT,LYON,FRANCE
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2825 / 2826
页数:2
相关论文
共 50 条
  • [21] Posttransplant lymphoproliferative disease: Treatment and outcome in renal transplant recipients
    Soler, MJ
    Puig, JM
    Mir, M
    Parrilla, J
    Pedro, C
    Salar, A
    Serrano, S
    Lloveras, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1709 - 1713
  • [22] Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab
    Kalra, Amit
    Roessner, Cameron
    Jupp, Jennifer
    Daly, Andrew
    Storek, Jan
    BLOOD, 2015, 126 (23)
  • [23] Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery
    Foroncewicz, B
    Mucha, K
    Usiekniewicz, J
    Chmura, A
    Kryst, P
    Soldacki, D
    Paczek, L
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (01) : 173 - 176
  • [24] Late-Onset Posttransplant Lymphoproliferative Disorder (PTLD) in a Renal Transplant Patient
    Denson, Joshua
    Maller, Abigail
    Mukherjee, Vikramjit
    Schrank, Gregory
    Amoroso, Nancy
    Schwartz, David
    CHEST, 2013, 144 (04)
  • [25] CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder
    Krishnamoorthy, Sambhavi
    Ghobadi, Armin
    Santos, Rowena D.
    Schilling, Joel D.
    Malone, Andrew F.
    Murad, Haris
    Bartlett, Nancy L.
    Alhamad, Tarek
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (02) : 809 - 814
  • [26] Posttransplant Lymphoproliferative Disorder Presenting as Multiple Cystic Lesions in a Renal Transplant Recipient
    Moir, J. A. G.
    Simms, R. J.
    Wood, K. M.
    Talbot, D.
    Kanagasundaram, N. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (01) : 245 - 249
  • [27] Cyclophosphamide conversion therapy for the treatment of posttransplant lymphoproliferative disorders.
    Radovancevic, B
    Riggs, SA
    Radovancevic, R
    Bracey, AW
    Frazier, OH
    BLOOD, 1999, 94 (10) : 266B - 266B
  • [28] Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients
    Berney, T
    Delis, S
    Kato, T
    Nishida, S
    Mittal, NK
    Madariaga, J
    Levi, D
    Nery, NR
    Cirocco, RE
    Gelman, B
    Ruiz, P
    Tzakis, AG
    TRANSPLANTATION, 2002, 74 (07) : 1000 - 1006
  • [29] High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder
    Chen, RW
    Sweetenham, JJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 211 - 212
  • [30] The Diagnosis and Treatment of Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients
    Liu, Jing-Yi
    Sun, Li-Ying
    Zhu, Zhi-Jun
    Wei, Lin
    Liu, Ying
    Zeng, Zhi-Gui
    Qu, Wei
    TRANSPLANTATION, 2022, 106 (09) : S482 - S482